行情

BDX

BDX

碧迪
NYSE

实时行情|Nasdaq Last Sale

248.30
-0.50
-0.20%
盘后: 248.30 0 0.00% 16:41 11/15 EST
开盘
250.11
昨收
248.80
最高
250.46
最低
247.34
成交量
115.71万
成交额
--
52周最高
264.74
52周最低
208.62
市值
670.30亿
市盈率(TTM)
67.17
分时
5日
1月
3月
1年
5年

分析师评级

17位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

BDX 新闻

  • BD Recommends Stockholders Reject Mini-Tender Offer by TRC Capital Investment Corporation
  • PR Newswire.2天前
  • BD to Present at Jefferies 2019 London Healthcare Conference
  • PR Newswire.3天前
  • 9 Super-Safe-Growth Stocks for Long-Lasting Dividends
  • InvestorPlace.4天前
  • 10 Biggest Price Target Changes For Wednesday
  • Benzinga.4天前

更多

所属板块

医疗设备、用品及经销
+1.05%
医疗设备和用品
+1.69%

热门股票

名称
价格
涨跌幅

BDX 简况

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.
展开

Webull提供Becton Dickinson and Co的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。